Mediflaza 6mg Tablet DEFLAZACORT

Introduction to Mediflaza 6mg Tablet

Mediflaza 6mg Tablet is a medication primarily used to treat a condition known as Duchenne muscular dystrophy (DMD) in children aged 5 and older. This condition leads to muscle weakening, and Mediflaza helps manage its symptoms.

Composition of Mediflaza 6mg Tablet

The active ingredient in Mediflaza 6mg Tablet is Deflazacort. This component is crucial for its therapeutic effects.

Uses of Mediflaza 6mg Tablet

• Management of Duchenne muscular dystrophy (DMD) in children.
• Reduction of inflammation in the body.
• Suppression of the immune system to prevent further muscle damage.

Side effects of Mediflaza 6mg Tablet

Common side effects:

• Weight gain
• Increased appetite
• Round face (Cushingoid appearance)
• Upper respiratory infections (common cold)
• Frequent urination
• Nose and throat inflammation
• Excessive hair growth
• Irritability

Serious side effects:

• Allergic reactions such as rash, itching, or swelling
• Severe dizziness
• Trouble breathing

Precautions of Mediflaza 6mg Tablet

Mediflaza should not be taken by individuals who are allergic to Deflazacort or any of its ingredients. It should be used with caution during pregnancy and breastfeeding. Stopping the medication suddenly can lead to steroid withdrawal syndrome, which includes symptoms like loss of appetite, nausea, vomiting, tiredness, and headache.

How to Take Mediflaza 6mg Tablet

• Take Mediflaza once daily by mouth.
• The recommended dose is about 0.9 mg for each kilogram of body weight.
• It can be taken with or without food.
• Avoid taking it with grapefruit juice.

Conclusion of Mediflaza 6mg Tablet

Mediflaza 6mg Tablet is an effective medication for managing Duchenne muscular dystrophy in children. It works by reducing inflammation and suppressing the immune system. However, it is important to be aware of its side effects and take necessary precautions while using it. Always consult with a healthcare professional before starting or stopping the medication.